Guatemala city, Guatemala Clinical Trials

A listing of Guatemala city, Guatemala clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 21 clinical trials
Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)

This study will evaluate the efficacy and safety of olaparib (MK-7339) monotherapy in participants with multiple types of advanced cancer (unresectable and/or metastatic) that: 1) have progressed or been intolerant to standard of care therapy; and 2) are positive for homologous recombination repair mutation (HRRm) or homologous recombination deficiency (HRD).

Centro Regional de Sub Especialidades Medicas SA ( Site 3003)
 (69.2 away) Contact site
  • 175 views
  • 23 Sep, 2021
  • +146 other locations
A Study of Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Participants From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (MK-1986-018)

This study will evaluate the safety, tolerability, and efficacy of tedizolid phosphate (MK-1986) compared with comparator antibacterial agent in participants from birth to less than 12 years of age with acute bacterial skin and skin structure infections (ABSSSI).

Clinica Privada ( Site 0551)
 (0.4 away) Contact site
  • 81 views
  • 12 Sep, 2021
  • +60 other locations
A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)

The main purpose of this study is to evaluate the antitumor activity and safety of Lenvatinib (MK-7902/E7080) in children, adolescents, and young adults with relapsed or refractory solid malignancies after administration. Participants will be enrolled into initial tumor-specific cohorts which will be expanded based on observed response.

Mary Crowley Cancer Research Center ( Site 0107)
 (1317.2 away) Contact site
  • 0 views
  • 20 Sep, 2021
  • +49 other locations
Efficacy of Emotionally Focused Therapy Among Spanish Speaking Couples

70 couples (married or cohabiting) will be recruited across 5 countries (12-18 in each country: Argentina, Costa Rica, Guatemala, Mxico, and Spain). After their entry into the study is confirmed, couples will be randomly allocated into one of two groups: intervention or control (no intervention). In each country, both groups …

Consultorio Alfonso Villareal
 (443.0 away) Contact site
  • 1 views
  • 20 Sep, 2021
  • +12 other locations
Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)

This study aims to evaluate the safety, tolerability and efficacy of molnupiravir (MK-4482) compared to placebo. The primary hypothesis is that molnupiravir is superior to placebo as assessed by the percentage of participants who are hospitalized and/or die through Day 29

Cl nica M dica Especializada en Pediatr a e Infectolog a Pedi trica - Dr. Mario Melgar ( Site 2601)
 (2.7 away) Contact site
  • 38 views
  • 23 Sep, 2021
  • +161 other locations
Assessing the Impact of Lipoprotein (a) Lowering With TQJ230 on Major Cardiovascular Events in Patients With CVD

This is a pivotal phase 3 study designed to support an indication for the reduction of cardiovascular risk in patients with established CVD and elevated Lp(a)

Novartis Investigative Site
 (2.7 away) Contact site
  • 151 views
  • 23 Sep, 2021
  • +578 other locations
Efficacy Safety and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169)

This study will evaluate the efficacy, safety, and pharmacokinetics (PK) of sugammadex (MK-8616) for reversal of both moderate and deep neuromuscular blockade (NMB) in pediatric participants aged birth to <2 years. The primary hypothesis of this study is that sugammadex is superior to neostigmine in reversing moderate NMB as measured …

vecuronium
glycopyrrolate
atropine
sugammadex
neostigmine
Centenario Hospital Miguel Hidalgo ( Site 4152)
 (916.7 away) Contact site
  • 4 views
  • 22 Sep, 2021
  • +37 other locations
Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)

The purpose of this study is to assess the efficacy and safety of treatment with olaparib (MK-7339) in combination with pembrolizumab (MK-3475) in adults with previously treated, advanced (metastatic and/or unresectable) Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-positive solid tumors.

pembrolizumab
advanced cancer
cancer
solid tumor
cancer of the ovary
Centro Medico Integral de Cancerologia CEMIC ( Site 3002)
 (65.5 away) Contact site
  • 19 views
  • 24 Sep, 2021
  • +150 other locations
Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

The purpose of this study is to assess the efficacy and safety of treatment with definitive chemoradiotherapy (dCRT) + pembrolizumab (MK-3475) compared to treatment with dCRT + placebo with respect to Overall Survival (OS) and Event-free Survival (EFS) in: participants with esophageal squamous cell carcinoma (ESCC), participants whose tumors express …

pembrolizumab
carcinoma
leucovorin
external radiation
mk-3475
Centro Medico Integral de Cancerologia CEMIC ( Site 0123)
 (65.5 away) Contact site
  • 32 views
  • 23 Sep, 2021
  • +152 other locations
Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)

This study will examine the safety and efficacy of pembrolizumab (MK-3475) in combination with chemotherapy in children and young adults with newly diagnosed classical Hodgkin Lymphoma (cHL) who are slow early responders (SERs) to frontline chemotherapy.

dacarbazine
vinblastine
prednisone
doxorubicin
cyclophosphamide
Hospital Infantil de Mexico Federico Gomez ( Site 0535)
 (656.9 away) Contact site
  • 23 views
  • 22 Sep, 2021
  • +80 other locations